Tasly Pharma

Tasly Pharmaceutical Group Co., Ltd., commonly known as Tasly, is a prominent Chinese pharmaceutical company with its headquarters in Tianjin, China. Founded in 1994, Tasly has rapidly grown to become a major player in the Chinese and global pharmaceutical markets.

Tasly is primarily focused on research, development, manufacturing, and marketing of modern Traditional Chinese Medicines (TCMs), as well as chemical-based pharmaceutical products. The company's product portfolio includes a wide range of therapeutic areas, including cardiovascular, cerebrovascular, gastrointestinal, and metabolic disorders.

One of Tasly's notable areas of expertise is in modern TCMs, where traditional Chinese medicine practices are integrated with modern scientific research and pharmaceutical standards. This approach sets Tasly apart and contributes to its success in addressing various health conditions.

The company places a strong emphasis on innovation and invests significantly in research and development to bring new and effective drugs to the market. It collaborates with domestic and international research institutions and pharmaceutical companies to enhance its capabilities.

Tasly also operates a robust distribution network and has an extensive presence in China. It has also been expanding its international footprint by entering into strategic partnerships and establishing subsidiaries and joint ventures in other countries.

Founded: 1994

Founder: Xiaoyu Chen

Headquarters: Tianjin, China

Website: https://en.tasly.com/